Sutro Biopharma (STRO) Tax Rate (2022 - 2026)

Sutro Biopharma (STRO) posted Tax Rate of 0.19% for Q4 2025, up 20.2% sequentially from 0.16% in Q2 2025, and up 355.0% YoY from 0.04% in Q4 2024.

Analysis

Sutro Biopharma (STRO) Tax Rate (2022 - 2026) Analysis & Trends

Sutro Biopharma has reported Tax Rate for 4 years, with the latest figure at 0.19% in Q4 2025.

Quarterly Tax Rate rose 355.0% year-over-year to 0.19% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 1.23% (up 685.0% YoY) and the FY2025 annual result came in at 0.05%, up 110.0% from the prior year.
Tax Rate improved to 0.19% in Q4 2025 per STRO's latest filing, from 0.16% in the prior quarter.
Over five years, Tax Rate peaked at 33.74% in Q4 2023 and troughed at 10.63% in Q2 2022.
A 4-year average of 1.67% and a median of 0.39% in 2023 frame the typical range for Tax Rate.
The sharpest annual moves came in 2023 and 2024: Tax Rate jumped 1024 bps in 2023, then sank 3710 bps in 2024.
Over 4 years, Tax Rate stood at 10.63% in 2022, then surged by 417 bps to 33.74% in 2023, then plunged by 110 bps to 3.36% in 2024, then surged by 106 bps to 0.19% in 2025.
According to Business Quant data, Tax Rate over the past three periods registered 0.19%, 0.16%, and 3.36% for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Vertex Pharmaceuticals	139.76 Bn	131.91 Bn	2.84 Bn	20.98%
2	Regeneron Pharmaceuticals	85.72 Bn	77.72 Bn	3.93 Bn	15.11%
3	Argenx Se	63.56 Bn	58.38 Bn	1.37 Bn	-10.89%
4	Moderna	57.87 Bn	52.73 Bn	52.00 Mn	-1.96%
5	Revolution Medicines	44.06 Bn	44.06 Bn	-	-
6	BeOne Medicines	40.08 Bn	34.98 Bn	1.53 Bn	24.15%
7	Alnylam Pharmaceuticals	35.50 Bn	32.20 Bn	992.69 Mn	7.49%
8	Royalty Pharma	28.54 Bn	27.70 Bn	-	-
9	Insmed	27.49 Bn	26.33 Bn	358.27 Mn	-16.71%
10	Sutro Biopharma	336.57 Mn	172.22 Mn	-	0.00%

Historic Data

Download Data